DRUG · Unmapped registry intervention
BI 456906
Find medicine records ·
Find other trials using this name
Clinical trial
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
NCT04153929
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Semaglutide
Normalized identity: semaglutideView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes.
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
Winston-SalemNorth Carolina, United States2ViennaAustria2Los AngelesCalifornia, United States1DallasTexas, United States1MiamiFlorida, United States1San AntonioTexas, United States1SeoulSouth Korea1BarcelonaSpain1MontrealQuebec, Canada1Las VegasNevada, United States1WarsawPoland1Chapel HillNorth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04153929 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.